Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe history now shows an added revision entry v3.6.3 and a removed revision entry v3.6.0, updating the page's versioning log. This change updates the metadata shown in the history section without altering study content or functionality.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note that recruitment is closed and updated the page revision to v3.6.0, replacing the previous v3.5.5 label.SummaryDifference0.2%

- Check27 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the history list, replacing the previous 'Revision: v3.5.4'. This represents a small site-build update reflected in the version history and does not change the underlying study records or user-facing content.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.5.4 appears in the page footer, replacing the previous v3.5.3. This indicates a small update to the site's revision tag within the Record History display.SummaryDifference0.0%

- Check63 days agoChange DetectedA new Completed status with Study Status and Recruitment Status entries was added, along with corresponding dates, and the prior Active, not recruiting status was removed. This documents that the trial has concluded and is no longer recruiting.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page’s displayed software/site revision was updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov release rather than any change to the underlying study record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.